Modern approaches to the diagnosis and treatment of cold contact urticaria

Current Allergy and Asthma Reports

Volumn 10, Issue 4, 2010, Pages 243-249

  Krause, Karoline ^a   Zuberbier, Torsten ^a   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antihistamine; Cold stimulation test; Cold urticaria; Physical urticaria; Threshold test; Treatment

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CAPSAICIN; CETIRIZINE; CYCLOSPORIN A; CYPROHEPTADINE; DESLORATADINE; DOXEPIN; EBASTINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MIZOLASTINE; PENICILLIN G; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RUPATADINE; TETRACYCLINE;

ANTICHOLINERGIC EFFECT; CLINICAL FEATURE; COLD SENSITIVITY; COLD TOLERANCE; COLD URTICARIA; CONTACT URTICARIA; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EMERGENCY CARE; HUMAN; IMMUNOPATHOGENESIS; LABORATORY DIAGNOSIS; PROGNOSIS; PROVOCATION TEST; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; ANGIOEDEMA; COLD; DIAGNOSTIC TEST; DRUG EFFECTS; FEMALE; MALE; MAST CELL; STANDARDS; URTICARIA; YOUNG ADULT;

ANGIOEDEMA; COLD TEMPERATURE; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; MALE; MAST CELLS; URTICARIA; YOUNG ADULT;

EID: 77956394667     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-010-0121-3     Document Type: Review

References (56)

1. Siebenhaar F, Weller K, Mlynek A, et al.: Acquired cold urticaria: Clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007, 32:241-245.
2. Magerl M, Borzova E, Gimenez-Arnau A, et al.: The definition and diagnostic testing of physical and cholinergic urticarias- EAACI/GALEN/EDF/UNEV consensus panel recommendations. Allergy 2009, 64:1715-1721.
3. Zuberbier T, Asero R, Bindslev-Jensen C, et al.: EAACI/GA(2) LEN/EDF/WAO guideline: Definition, classification and diagnosis of urticaria. Allergy 2009, 64:1417-1426.
4. Wanderer AA, Grandel KE, Wasserman SI, Farr RS: Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: Recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol 1986, 78:417-423.
5. Neittaanmaki H: Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol 1985, 13:636-644.
6. Alangari AA, Twarog FJ, Shih MC, Schneider LC: Clinical features and anaphylaxis in children with cold urticaria. Pediatrics 2004, 113:e313-e317.
7. Katsarou-Katsari A, Makris M, Lagogianni E, et al.: Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: A 10-year prospective study. J Eur Acad Dermatol Venereol 2008, 22:1405-1411.
8. Mathelier-Fusade P, Aissaoui M, Bakhos D, et al.: Clinical predictive factors of severity in cold urticaria. Arch Dermatol 1998, 134:106-107.
9. Moller A, Henning M, Zuberbier T, Czarnetzki-Henz BM: [Epidemiology and clinical aspects of cold urticaria]. Hautarzt 1996, 47:510-514.
10. Murphy GF, Austen KF, Fonferko E, Sheffer AL: Morphologically distinctive forms of cutaneous mast cell degranulation induced by cold and mechanical stimuli: An ultrastructural study. J Allergy Clin Immunol 1987, 80:603-611.
11. Kaplan AP, Beaven MA: In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol 1976, 67:327-332.
12. Wasserman SI, Soter NA, Center DM, Austen KF: Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 1977, 60:189-196.
13. Grandel KE, Farr RS, Wanderer AA, et al.: Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 1985, 313:405-409.
14. Ormerod AD, Kobza Black A, Dawes J, et al.: Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation. J Allergy Clin Immunol 1988, 82:586-589.
15. Tillie-Leblond I, Gosset P, Janin A, et al.: Tumor necrosis factoralpha release during systemic reaction in cold urticaria. J Allergy Clin Immunol 1994, 93:501-509.
16. Kaplan AP, Garofalo J, Sigler R, Hauber T: Idiopathic cold urticaria: In vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med 1981, 305:1074-1077.
17. Koda H, Kanaide A, Asahi M, Urabe H: Essential IgG cryoglobulinemia with purpura and cold urticaria. Arch Dermatol 1978, 114:784-786.
18. Doeglas HM, Rijnten WJ, Schroder FP, Schirm J: Cold urticaria and virus infections: A clinical and serological study in 39 patients. Br J Dermatol 1986, 114:311-318.
19. Miralles Lopez JC, Lopez Andreu FR, Sanchez-Gascon F, et al.: Cold urticaria associated with acute serologic toxoplasmosis. Allergol Immunopathol (Madr) 2005, 33:172-174.
20. Kranke B, Mayr-Kanhauser S, Aberer W: Helicobacter pylori in acquired cold urticaria. Contact Dermatitis 2001, 44:57-58.
21. Kalogeromitros D, Gregoriou S, Papaioannou D, et al.: Acquired primary cold contact urticaria after Hymenoptera sting. Clin Exp Dermatol 2004, 29:93-95.
22. Mathelier-Fusade P, Leynadier F: Acquired cold urticaria after jellyfish sting. Contact Dermatitis 1993, 29:273.
23. Kranke B, Mayr-Kanhauser S: Cold urticaria and angiotensin converting enzyme inhibitor. Acta Derm Venereol 2002, 82:149-150.
24. Wanderer AA, Hoffman HM: The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am 2004, 24:259-286, vii.
25. Siebenhaar F, Staubach P, Metz M, et al.: Peltier effect-based temperature challenge: An improved method for diagnosing cold urticaria. J Allergy Clin Immunol 2004, 114:1224-1225.
26. Mlynek A, Magerl M, Siebenhaar F, et al.: Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol 2009 Sep 28 (Epub ahead of print). This articles discusses the relevance of determining temperature thresholds in CCU patients in order to assess disease severity.
27. Kivity S, Schwartz Y, Wolf R, Topilsky M: Systemic cold-induced urticaria-clinical and laboratory characterization. J Allergy Clin Immunol 1990, 85:52-54.
28. Kaplan AP: Unusual cold-induced disorders: Cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol 1984, 73:453-456.
29. Kaplan AP, Garofalo J: Identification of a new physically induced urticaria: Cold-induced cholinergic urticaria. J Allergy Clin Immunol 1981, 68:438-441.
30. Matthews CN, Warin RP: Delayed cold urticaria. Br J Dermatol 1977, 97(Suppl 15):32.
31. Czarnetzki BM, Frosch PJ, Sprekeler R: Localized cold reflex urticaria. Br J Dermatol 1981, 104:83-87.
32. Wanderer AA: Systemic cold urticaria (atypical acquired cold urticaria). J Allergy Clin Immunol 1991, 87:137-138.
33. Hoffman HM, Mueller JL, Broide DH, et al.: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001, 29:301-305.
34. Hoffman HM, Wanderer AA, Broide DH: Familial cold autoinflammatory syndrome: Phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 2001, 108:615-620.
35. Soter NA, Joshi NP, Twarog FJ, et al.: Delayed cold-induced urticaria: A dominantly inherited disorder. J Allergy Clin Immunol 1977, 59:294-297.
36. Gandhi C, Healy C, Wanderer AA, Hoffman HM: Familial atypical cold urticaria: Description of a new hereditary disease. J Allergy Clin Immunol 2009, 124:1245-1250.
37. Zuberbier T, Asero R, Bindslev-Jensen C, et al.: EAACI/GA(2) LEN/EDF/WAO guideline: Management of urticaria. Allergy 2009, 64:1427-1443.
38. Wanderer AA, Ellis EF: Treatment of cold urticaria with cyproheptadine. J Allergy Clin Immunol 1971, 48:366-371.
39. Neittaanmaki H, Myohanen T, Fraki JE: Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: Usefulness of doxepin. J Am Acad Dermatol 1984, 11:483-489.
40. Church MK, Maurer M, Simons FER, et al.: Should first-generation H1-antihistamines still be available as over-the-counter medications? A GA2LEN task force report. Allergy 2010 (in press).
41. Juhlin L, de Vos C, Rihoux JP: Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. J Allergy Clin Immunol 1987, 80:599-602.
42. Dubertret L, Pecquet C, Murrieta-Aguttes M, Leynadier F: Mizolastine in primary acquired cold urticaria. J Am Acad Dermatol 2003, 48:578-583.
43. Magerl M, Schmolke J, Siebenhaar F, et al.: Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy 2007, 62:1465-1468.
44. Siebenhaar F, Degener F, Zuberbier T, et al.: High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebocontrolled, crossover study. J Allergy Clin Immunol 2009, 123:672-679. The efficacy and safety of high-dose, nonsedating antihistamines in the reduction of clinical symptoms in CCU is shown in a placebo-controlled, randomized trial.
45. Di Leo E, Nettis E, Cassano N, et al.: Treatment of acquired cold urticaria with rupatadine. Allergy 2009, 64:1387-1388.
46. Metz M, Scholz E, Ferran M, et al.: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in acquired cold urticaria. Ann Allergy Asthma Immunol 2010, 104:86-92.
47. Bonadonna P, Lombardi C, Senna G, et al.: Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol 2003, 49:714-716.
48. Marsland AM, Beck MH: Cold urticaria responding to systemic ciclosporin. Br J Dermatol 2003, 149:214-215.
49. Boyce JA: Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006, 117:1415-1418.
50. Bodar EJ, Simon A, de Visser M, van der Meer JW: Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med 2009, 67:302-305. The good response to anti-interleukin-1 in a case of severe CCU suggests a possible role for interleukin-1 not only in the pathogenesis of cryopyrin-associated periodic syndromes but also in CCU.
51. Bird JA, Burks W: Peanut allergy saves a patient with coldinduced hypotension and urticaria. J Pediatr 2010, 156:687.
52. Toth-Kasa I, Jancso G, Obal F Jr, et al.: Involvement of sensory nerve endings in cold and heat urticaria. J Invest Dermatol 1983, 80:34-36.
53. Keahey TM, Indrisano J, Kaliner MA: A case study on the induction of clinical tolerance in cold urticaria. J Allergy Clin Immunol 1988, 82:256-261.
54. von Mackensen YA, Sticherling M: Cold urticaria: Tolerance induction with cold baths. Br J Dermatol 2007, 157:835-836.
55. Hoffman HM, Throne ML, Amar NJ, et al.: Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrinassociated periodic syndromes: Results from two sequential placebo-controlled studies. Arthritis Rheum 2008, 58:2443-2452.
56. Goldbach-Mansky R, Kastner DL: Autoinflammation: The prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol 2009, 124:1141-1149; quiz 1150-1151.